Raised erythrocyte sedimentation rate signals heart failure in patients with rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 66, Issue 1, 2007, Pages 76-80

  Maradit Kremers, H ^a   Nicola, P J ^a   Crowson, C S ^a   Ballman, K V ^a   Jacobsen, S J ^a   Roger, V L ^a   Gabriel, Sherine E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; ARTICLE; COHORT ANALYSIS; DEATH; ERYTHROCYTE SEDIMENTATION RATE; FOLLOW UP; HEART FAILURE; HUMAN; INCIDENCE; INFLAMMATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ACUTE-PHASE REACTION; ADULT; ANEMIA; ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES;

EID: 33845984859     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.053710     Document Type: Article

References (27)

1. Nicola PJ, Maradit-Kremers H, Roger VL, Jacobsen SJ, Crowson CS, Ballman KV, et al. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum 2005;52:412-20.
2. Crowson CS, Nicola PJ, Maradit Kremers H, O'Fallon WM, Therneau TM, Jacobsen SJ, et al. How much of the increased incidence of heart Failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischaemic heart disease? Arthritis Rheum 2005;52:3039-44.
3. Mann DL. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 2002;91:988-98.
4. American College of Rheumatology Subcommittee on Rheumatoid Arthritis G. Guidelines for the management of rheumatoid arthritis: 2002 update. Arihritis Rheum 2002;46:328-46.
5. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-54.
6. Donald F, Ward MM. Evaluative laboratory testing practices of United States rheumatologists. Arthritis Rheum 1998;41:725-9.
7. Haber HL, Leavy JA, Kessler PD, Kukin ML, Gottlieb SS, Packer M. The erythrocyte sedimentation rate in congestive heart failure. N Engl J Med 1991;324:353-8.
8. Sharma R, Rauchhaus M, Ponikowski PP, Varney S, Poole-Wilson PA, Mann DL, et al. The relationship of the erythrocyte sedimentation rate to inflammatory cytokines and survival in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. J Am Coll Cardiol 2000;36:523-8.
9. Vosan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, et al. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study [comment]. Circulation 2003;107:1486-91.
10. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study [comment]. Circulation 2003;108:2317-22.
11. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 2001;103:2055-9.
12. Melton L. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996;71:266-74.
13. Maradit Kremers H, Crowson CS, Gabriel SE. Rochester Epidemiology Project: a unique resource for research in the rheumatic diseases. Rheum Dis Clin North Am 2004;30:819-34.
14. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005;52:722-32.
15. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
16. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441-6.
17. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
18. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003;289:2560-71.
19. Ward MM. Evaluative laboratory testing. Assessing tests that assess disease activity. Arthritis Rheum 1995;38:1555-63.
20. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 1993;36:729-40.
21. Donald F, Ward MM. Evaluative laboratory testing practices of United States rheumatologists. Arthritis Rheum 1998;41:725-9.
22. Paulus HE, Ramos B, Wong WK, Ahmed A, Bulpitt K, Park G. Equivalence of the acute phase reactants C-reactive protein, plasma viscosity, and Westergren erythrocyte sedimentation rate when used to calculate American College of Rheumatology 20% improvement criteria of the Disease Activity Score in patients with early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists. J Rheumatol 1999;26:2324-31.
23. Androne AS, Katz SD, Lund L, LaManca J, Hudaihed A, Hryniewicz K. Hemodilution is common in patients with advanced heart failure. Circulation 2003;107:226-9.
24. Means RT Jr. Recent developments in the anemia of chronic disease. Curr Hematol Rep 2003;2:116-21.
25. Weiss G, Goodnough LT. Medical progress: anemia of chronic disease. N Engl J Med 2005;352:1011-23.
26. Sox HC Jr, Liang MH. The erythrocyte sedimentation rate. Guidelines for rational use. Ann Intern Med 1986;104:515-23.
27. Wolfe F. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis. J Rheumatol 1997;24:1477-85.